VERDENCE CAPITAL ADVISORS LLC – Halozyme Therapeutics, Inc. Transaction History
VERDENCE CAPITAL ADVISORS LLC portfolio value:
$620,000
portfolio value
VERDENCE CAPITAL ADVISORS LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.95% | 148 shares | -63K | $39.54 | 15.67K |
| Q2 2022 | share | Increase | +10.75% | 1.50K shares | 124K | $44 | 15.52K |
| Q1 2022 | share | Increase | +1.82% | 251 shares | 5K | $39.88 | 14.02K |
| Q4 2021 | share | Increase | +19.86% | 2.28K shares | 87K | $40.32 | 13.77K |
| Q3 2021 | share | Decrease | -0.06% | -7 shares | -55K | $40.68 | 11.48K |
| Q2 2021 | share | Decrease | -0.31% | -36 shares | 41K | $45.41 | 11.49K |
| Q1 2021 | share | Decrease | -0.17% | -20 shares | -12K | $41.69 | 11.53K |
| Q4 2020 | share | Increase | +1.43% | 163 shares | 194K | $42.71 | 11.55K |
| Q3 2020 | share | 0.00% | 0 shares | -6K | $26.28 | 11.38K | |
| Q2 2020 | share | 0.00% | 0 shares | 100K | $26.81 | 11.38K | |
| Q1 2020 | share | 0.00% | 0 shares | 3K | $17.99 | 11.38K | |
| Q4 2019 | share | 0.00% | 0 shares | 25K | $17.73 | 11.38K | |
| Q3 2019 | share | 0.00% | 0 shares | -19K | $15.51 | 11.38K | |
| Q2 2019 | share | 0.00% | 0 shares | 13K | $17.18 | 11.38K | |
| Q1 2019 | share | 0.00% | 0 shares | 16K | $16.1 | 11.38K | |
| Q4 2018 | share | 0.00% | 0 shares | -40K | $14.63 | 11.38K | |
| Q3 2018 | share | 0.00% | 0 shares | 15K | $18.17 | 11.38K | |
| Q2 2018 | share | 0.00% | 0 shares | -31K | $16.87 | 11.38K | |
| Q1 2018 | share | 0.00% | 0 shares | -8K | $19.59 | 11.38K | |
| Q4 2017 | share | Increase | 0.00% | 11.38K shares | 231K | $20.26 | 11.38K |